AI Literacy in Clinical Trials Under ICH E6(R3)
AI-supported workflows in clinical trials increasingly fall within GCP, computerized system, data integrity, and AI governance expectations. Sponsors and CROs need teams that understand oversight, validation, accountability, and responsible AI use.
Risk-based quality management in 2026
Risk-based quality management in 2026: how ICH E6(R3) defines RBQM, where practice diverges, and what regulators now expect in clinical trials.
AI-Driven Predictive Analytics in Risk-Based Monitoring
Discover how AI-driven predictive analytics is reshaping risk-based monitoring under ICH E6(R3), enabling earlier intervention and stronger oversight.
The Cost of Poor Quality in Clinical Trials & How to Avoid It
Protocol changes and preventable risks can delay trials and drive major costs. Learn why proactive quality planning and RBQM lead to more predictable outcomes.
Phase III Oncology: Targeted Risk-Based QA Case Study
How ADAMAS used AI-augmented RBQM analytics to strengthen oversight, focus QA effort, and improve inspection readiness in a global Phase III oncology study.
Site Readiness Under ICH E6(R3)
Key expectations for site readiness under ICH E6(R3), including documentation, risk-based oversight, and digital data governance.
ICH E6(R3) Final Guideline: What You Need to Know
ICH E6(R3) is now adopted. Learn what changes for sponsors, CROs, and sites, including accountability, CtQ planning, proactive monitoring, and participant protection.
Site Readiness Tips
Practical steps trial sites can take to align with ICH E6(R3) expectations for training, data governance, and risk-based monitoring.
Sponsor Responsibilities in ICH E6(R3)
What E6(R3) means for sponsor accountability, oversight, and documentation — plus a practical sponsor responsibilities infographic.
Milestone | We Have Just Received our ISO 9001:2015 Certificate
Cyntegrity is now ISO 9001:2015 certified. Learn how this strengthens quality governance, continuous improvement, and trust in AI-augmented RBQM solutions.
